David BUMCROT D,Dinah Wen-Yee SAH DW-Y,Ivanka TOUDJARSKA I,‧邦姆克羅特,‧沙,‧圖德雅斯卡
申请号：
HK16108503.5
公开号：
HK1220380A
申请日:
2016.07.18
申请国别(地区):
HK
年份:
2017
代理人:
摘要：
This invention relates to compositions containing double-stranded ribonucleic acid (dsRNA) in a SNALP formulation, and methods of using the compositions to inhibit the expression of the Eg5 and Vascular Endothelial Growth Factor (VEGF), and methods of using the compositions to treat pathological processes mediated by Eg5 and VEGF expression, such as cancer.
